董事介绍

姓名 性别 职位 年龄 薪酬 截止日期
George Paz 董事长 -- 1483.56万(USD) 2017-02-14
Timothy Wentworth 董事,总裁兼首席执行官 56 846.49万(USD) 2017-02-14
Thomas P. Mac Mahon -- 董事 -- 30.75万(USD) 2017-02-14
William J. DeLaney 董事 -- 29.55万(USD) 2017-02-14
Frank Mergenthaler -- 董事 -- 29.38万(USD) 2017-02-14
Woodrow A. Myers, Jr. 董事 -- 29.25万(USD) 2017-02-14
Seymour Sternberg -- 董事 -- 28.85万(USD) 2017-02-14
Nicholas J. LaHowchic 董事 -- 28.60万(USD) 2017-02-14
Maura C. Breen 董事 -- 27.85万(USD) 2017-02-14
William L. Roper 董事 -- 27.18万(USD) 2017-02-14
Roderick A. Palmore 董事 -- 27.00万(USD) 2017-02-14
Elder Granger 董事 -- 15.79万(USD) 2017-02-14

高管介绍

姓名 性别 职位 年龄 薪酬 截止日期
Timothy Wentworth 董事,总裁兼首席执行官 56 846.49万(USD) 2017-02-14
Sara Wade 高级副总裁兼首席人力资源官 47 351.87万(USD) 2017-02-14
Christine Houston 执行副总裁兼首席运营官 54 334.33万(USD) 2017-02-14
Eric Slusser 执行副总裁兼首席财务官 56 161.14万(USD) 2017-02-14
Phyllis Anderson 高级副总裁兼首席营销官 57 -- 2017-02-14
Martin Akins 高级副总裁,总法律顾问兼公司秘书 50 -- 2017-02-14
Steven Miller -- 高级副总裁-首席医疗官 59 -- 2017-02-14
Everett Neville 供应链高级副总裁 52 -- 2017-02-14
David Queller 高级副总裁-销售和客户管理 48 -- 2017-02-14
Neal Sample 高级副总裁兼首席信息官 42 -- 2017-02-14
Christopher McGinnis 副总裁兼首席会计官兼公司财务总监 45 -- 2017-02-14
Glen Stettin 高级副总裁-临床研究和新解决方案,首席创新官 53 -- 2017-02-14

董事简历

中文 |  英文 |  中英对照
George Paz
George Paz., 自2006年5月担任快捷药方一家持股公司--药房福利管理公司董事会主席;2005年4月起担任首席执行官;2003年10月到2014年2月担任总裁。自2004年1月起开始担任快捷药方董事。1998年1月加入快捷药方担任高级副总裁兼首席财务官,2004年4月被选为总裁,从而辞去首席财务官一职。他是一名注册会计师。
George Paz,has served as Chairman of the Board of Express Scripts, a pharmacy benefit management company, since May 2006 as Chief Executive Officer since April 2005 and as President from October 2003 to February 2014. He has served as a director of Express Scripts since January 2004. Mr. Paz joined Express Scripts as Senior Vice President and Chief Financial Officer in January 1998 and continued to serve as its Chief Financial Officer following his election as President until April 2004. Mr. Paz is a Certified Public Accountant. He is also a director of Prudential Financial, Inc.
George Paz,has served as Chairman of the Board of Express Scripts, a pharmacy benefit management company, since May 2006 as Chief Executive Officer since April 2005 and as President from October 2003 to February 2014. He has served as a director of Express Scripts since January 2004. Mr. Paz joined Express Scripts as Senior Vice President and Chief Financial Officer in January 1998 and continued to serve as its Chief Financial Officer following his election as President until April 2004. Mr. Paz is a Certified Public Accountant. He is also a director of Prudential Financial, Inc.

George Paz., 自2006年5月担任快捷药方一家持股公司--药房福利管理公司董事会主席;2005年4月起担任首席执行官;2003年10月到2014年2月担任总裁。自2004年1月起开始担任快捷药方董事。1998年1月加入快捷药方担任高级副总裁兼首席财务官,2004年4月被选为总裁,从而辞去首席财务官一职。他是一名注册会计师。

Timothy Wentworth
Timothy Wentworth , 2014年2月被任命为公司总裁。从2012年4月到2014年2月,担任销售与客户管理部门高级副总裁。2012年4月快捷药方公司与美可保健公司合并,他于此时加入快捷药方公司。在美可保健公司,他从2008年10月到2012年4月担任全国重要客户集团总裁;2006年3月到2008年10月担任美可保健的附属子公司Accredo健康集团首席执行光;2003年8月到2006年3月担任全国客户集团总裁。
Timothy Wentworth assumed the role of Chief Executive Officer on May 4 2016 and has served as President of the Company since February 2014. Mr. Wentworth was elected a director of the Company in June 2015. From April 2012 to February 2014 he served as Senior Vice President and President, Sales and Account Management. Mr. Wentworth joined Express Scripts when the Company merged with Medco in April 2012. At Medco, he served as Group President, National and Key Accounts from October 2008 to April 2012 as Chief Executive Officer of Medco’s Accredo Health Group subsidiary from March 2006 to October 2008 and as Group President - National Accounts from August 2003 to March 2006.
Timothy Wentworth assumed the role of Chief Executive Officer on May 4 2016 and has served as President of the Company since February 2014. Mr. Wentworth was elected a director of the Company in June 2015. From April 2012 to February 2014 he served as Senior Vice President and President, Sales and Account Management. Mr. Wentworth joined Express Scripts when the Company merged with Medco in April 2012. At Medco, he served as Group President, National and Key Accounts from October 2008 to April 2012 as Chief Executive Officer of Medco’s Accredo Health Group subsidiary from March 2006 to October 2008 and as Group President - National Accounts from August 2003 to March 2006.

Timothy Wentworth , 2014年2月被任命为公司总裁。从2012年4月到2014年2月,担任销售与客户管理部门高级副总裁。2012年4月快捷药方公司与美可保健公司合并,他于此时加入快捷药方公司。在美可保健公司,他从2008年10月到2012年4月担任全国重要客户集团总裁;2006年3月到2008年10月担任美可保健的附属子公司Accredo健康集团首席执行光;2003年8月到2006年3月担任全国客户集团总裁。

Thomas P. Mac Mahon
Thomas P. Mac Mahon, 2001年3月被选为快捷药方的董事,自2008年5月起担任主持董事。他曾担任董事会主席、总裁兼首席执行官,1997年1月至2006年12月,曾经担任由美国持股的实验室公司(美国第二大独立的临床试验公司)行政与管理委员会成员。曾经担任并一直担任各大上市公司和私人公司董事。1995年到2013年担任实验室公司董事,2007年到2009年担任金色池塘医疗保健董事。他也是两家刚起步的诊断公司的董事,SYNAP诊断和Aushon生物系统公司。他现在是PharMerica公司的董事。
Thomas P. Mac Mahon, was elected a director of Express Scripts in March 2001 and has served as Presiding Director since May 2008. Mr. Mac Mahon served as Chairman of the Board, President and Chief Executive Officer and a member of the Executive and Management Committees of Laboratory Corporation of America Holdings or “LabCorp,” the second largest independent clinical laboratory company in the U.S., from January 1997 until his retirement in December 2006. Mr. Mac Mahon has also served or serves on the boards of several public and private companies. Mr. Mac Mahon served as a director of LabCorp from 1995 to 2013 and Golden Pond Healthcare from 2007 to 2009. Mr. Mac Mahon also serves as a director of two start-up diagnostic companies, SYNAP Diagnostics and Aushon Biosystems. He currently serves as a director of PharMerica Corporation.
Thomas P. Mac Mahon, was elected a director of Express Scripts in March 2001 and has served as Presiding Director since May 2008. Mr. Mac Mahon served as Chairman of the Board, President and Chief Executive Officer and a member of the Executive and Management Committees of Laboratory Corporation of America Holdings or “LabCorp,” the second largest independent clinical laboratory company in the U.S., from January 1997 until his retirement in December 2006. Mr. Mac Mahon has also served or serves on the boards of several public and private companies. Mr. Mac Mahon served as a director of LabCorp from 1995 to 2013 and Golden Pond Healthcare from 2007 to 2009. Mr. Mac Mahon also serves as a director of two start-up diagnostic companies, SYNAP Diagnostics and Aushon Biosystems. He currently serves as a director of PharMerica Corporation.

Thomas P. Mac Mahon, 2001年3月被选为快捷药方的董事,自2008年5月起担任主持董事。他曾担任董事会主席、总裁兼首席执行官,1997年1月至2006年12月,曾经担任由美国持股的实验室公司(美国第二大独立的临床试验公司)行政与管理委员会成员。曾经担任并一直担任各大上市公司和私人公司董事。1995年到2013年担任实验室公司董事,2007年到2009年担任金色池塘医疗保健董事。他也是两家刚起步的诊断公司的董事,SYNAP诊断和Aushon生物系统公司。他现在是PharMerica公司的董事。

William J. DeLaney
William J. DeLaney, 2011年9月被任命为快捷药方公司董事,自2009年3月起任西斯科公司(食品营销和分销公司)首席执行官,一直到现在。2010年3月担任西斯科公司总裁。1987年他开始在西斯科任职,并担任各种不同职位。2007年7月他成为西斯科公司行政副总裁和首席财务官,直到2009年10月才退下。自2009年1月他就是西斯科公司的董事会成员。
William J. DeLaney earned a Bachelor of Business Administration degree from the University of Notre Dame, and a Master of Business Administration degree from the Wharton Graduate Division of the University of Pennsylvania. Mr. DeLaney has worked in various capacities at Sysco and its subsidiaries for more than 25 years. Through various accounting, finance, operations and management positions within Sysco and its operating companies, Mr. DeLaney has gained valuable insight into the foodservice industry, as well as Sysco’s competitive advantages and how to further build upon them. Throughout his career, Mr. DeLaney has developed experience and knowledge in the areas of leadership and management development, corporate strategy development, finance and accounting and distribution and supply chain management.
William J. DeLaney earned a Bachelor of Business Administration degree from the University of Notre Dame, and a Master of Business Administration degree from the Wharton Graduate Division of the University of Pennsylvania. Mr. DeLaney has worked in various capacities at Sysco and its subsidiaries for more than 25 years. Through various accounting, finance, operations and management positions within Sysco and its operating companies, Mr. DeLaney has gained valuable insight into the foodservice industry, as well as Sysco’s competitive advantages and how to further build upon them. Throughout his career, Mr. DeLaney has developed experience and knowledge in the areas of leadership and management development, corporate strategy development, finance and accounting and distribution and supply chain management.

William J. DeLaney, 2011年9月被任命为快捷药方公司董事,自2009年3月起任西斯科公司(食品营销和分销公司)首席执行官,一直到现在。2010年3月担任西斯科公司总裁。1987年他开始在西斯科任职,并担任各种不同职位。2007年7月他成为西斯科公司行政副总裁和首席财务官,直到2009年10月才退下。自2009年1月他就是西斯科公司的董事会成员。

Frank Mergenthaler
Frank Mergenthaler, 2009年1月被任命为快捷药方董事。担现任埃培智集团公司(一家广告及市场推广服务公司)行政副总裁兼首席财务官,自2005年7月起便开始任职该公司。曾经担任哥伦比亚众议院公司(娱乐节目的直接营销商)行政副总裁兼首席财务官。
Frank Mergenthaler, was elected a director of Express Scripts in January 2009. He is currently Executive Vice President and Chief Financial Officer of Interpublic Group of Companies, Inc., an advertising and marketing services company, and has served in this capacity since July 2005. From April 2002 to July 2005 Mr. Mergenthaler was Executive Vice President and Chief Financial Officer of Columbia House Company, a direct marketer of entertainment content.
Frank Mergenthaler, was elected a director of Express Scripts in January 2009. He is currently Executive Vice President and Chief Financial Officer of Interpublic Group of Companies, Inc., an advertising and marketing services company, and has served in this capacity since July 2005. From April 2002 to July 2005 Mr. Mergenthaler was Executive Vice President and Chief Financial Officer of Columbia House Company, a direct marketer of entertainment content.

Frank Mergenthaler, 2009年1月被任命为快捷药方董事。担现任埃培智集团公司(一家广告及市场推广服务公司)行政副总裁兼首席财务官,自2005年7月起便开始任职该公司。曾经担任哥伦比亚众议院公司(娱乐节目的直接营销商)行政副总裁兼首席财务官。

Woodrow A. Myers, Jr.
Woodrow A. Myers, Jr.自2011年3月以来担任公司董事。他自2005年12月以来是医疗和教育咨询公司Myers Ventures LLC的董事总经理。他从2000年到2005年是商业健康保险公司WellPoint, Inc.的执行副总裁和首席医疗官。从1995年到2000年他是the Ford Motor Company的医疗管理主管。他目前是Express Scripts, Inc.和Genomic Health, Inc.的董事,是Mozambique Healthcare Consortium的董事长。此外,他在过去的五年里担任其他上市公司的董事,包括ThermoGenesis Corp.(从2006年6月到2009年12月)和CardioNet, Inc.(从2007年8月到2009年5月)。他是纽约市和印第安纳州的前任卫生专员,哈佛大学公共卫生学院(Harvard School of Public Health)巡视委员会(visiting committee)的前任主席,是哈佛大学校监委员会(the Harvard University Board of Overseers)和斯坦福大学理事会(the Stanford University Board of Trustees)的成员。他获得斯坦福大学(Stanford University)生物科学学士学位,哈佛大学医学院(Harvard Medical School)医学博士学位和斯坦福大学(Stanford University)工商管理硕士学位。
Woodrow A. Myers, Jr., Dr. Myers has served as a director of the Company since March 2011. He has served as managing director of Myers Ventures LLC, a healthcare and education consulting company, since December 2005. He was the executive vice president and chief medical officer of WellPoint, Inc., a commercial health benefits company, from 2000 to 2005. From 1995 to 2000 Dr. Myers also served as the director of healthcare management at the Ford Motor Company. Dr. Myers currently serves as a director of Express Scripts, Inc. and Genomic Health, Inc. and serves as the chairman of the board of the Mozambique Healthcare Consortium. In addition, Dr. Myers has served as a director of other public companies within the last five years, including ThermoGenesis Corp. from June 2006 to December 2009 and CardioNet, Inc. from August 2007 to May 2009. He is a former health commissioner for New York City and the State of Indiana, past chairman of the visiting committee for the Harvard School of Public Health and has served as a member of the Harvard University Board of Overseers and the Stanford University Board of Trustees. Dr. Myers holds a B.S. degree in biological sciences from Stanford University, an M.D. degree from Harvard Medical School and an M.B.A. degree from Stanford University.
Woodrow A. Myers, Jr., Dr. Myers has served as a director of the Company since March 2011. He has served as managing director of Myers Ventures LLC, a healthcare and education consulting company, since December 2005. He was the executive vice president and chief medical officer of WellPoint, Inc., a commercial health benefits company, from 2000 to 2005. From 1995 to 2000 Dr. Myers also served as the director of healthcare management at the Ford Motor Company. Dr. Myers currently serves as a director of Express Scripts, Inc. and Genomic Health, Inc. and serves as the chairman of the board of the Mozambique Healthcare Consortium. In addition, Dr. Myers has served as a director of other public companies within the last five years, including ThermoGenesis Corp. from June 2006 to December 2009 and CardioNet, Inc. from August 2007 to May 2009. He is a former health commissioner for New York City and the State of Indiana, past chairman of the visiting committee for the Harvard School of Public Health and has served as a member of the Harvard University Board of Overseers and the Stanford University Board of Trustees. Dr. Myers holds a B.S. degree in biological sciences from Stanford University, an M.D. degree from Harvard Medical School and an M.B.A. degree from Stanford University.

Woodrow A. Myers, Jr.自2011年3月以来担任公司董事。他自2005年12月以来是医疗和教育咨询公司Myers Ventures LLC的董事总经理。他从2000年到2005年是商业健康保险公司WellPoint, Inc.的执行副总裁和首席医疗官。从1995年到2000年他是the Ford Motor Company的医疗管理主管。他目前是Express Scripts, Inc.和Genomic Health, Inc.的董事,是Mozambique Healthcare Consortium的董事长。此外,他在过去的五年里担任其他上市公司的董事,包括ThermoGenesis Corp.(从2006年6月到2009年12月)和CardioNet, Inc.(从2007年8月到2009年5月)。他是纽约市和印第安纳州的前任卫生专员,哈佛大学公共卫生学院(Harvard School of Public Health)巡视委员会(visiting committee)的前任主席,是哈佛大学校监委员会(the Harvard University Board of Overseers)和斯坦福大学理事会(the Stanford University Board of Trustees)的成员。他获得斯坦福大学(Stanford University)生物科学学士学位,哈佛大学医学院(Harvard Medical School)医学博士学位和斯坦福大学(Stanford University)工商管理硕士学位。

Seymour Sternberg
Seymour Sternberg, 1992年3月被任命为快捷药方董事。1997年4月被任命为纽约人寿首席执行官兼董事会主席,直到2008年6月从首席执行官职位上退下。他一直担任纽约人寿董事会非执行主席,直到2009年5月才退休。他被前总统克林顿任命为亚太经济合作组织工商咨询理事会三大代表之一。他曾经担任并一直担任多个上市公司、私人公司和慈善组织董事。现任西北大学和CIT有限集团董事。
Seymour Sternberg, was elected a director of Express Scripts in March 1992. Mr. Sternberg became Chief Executive Officer and Chairman of the Board of New York Life in April 1997 and served as Chief Executive Officer until his retirement in June 2008. Mr. Sternberg continued to serve as non-executive Chairman of the Board of New York Life until May 2009. Mr. Sternberg was appointed by former President Clinton as one of three U.S. representatives to the Business Advisory Council of the Asia-Pacific Economic Cooperation. Mr. Sternberg has also served or serves on the boards of several public or private companies and charitable organizations. Mr. Sternberg is currently a director of CIT Group Inc. and a director of Northeastern University.
Seymour Sternberg, was elected a director of Express Scripts in March 1992. Mr. Sternberg became Chief Executive Officer and Chairman of the Board of New York Life in April 1997 and served as Chief Executive Officer until his retirement in June 2008. Mr. Sternberg continued to serve as non-executive Chairman of the Board of New York Life until May 2009. Mr. Sternberg was appointed by former President Clinton as one of three U.S. representatives to the Business Advisory Council of the Asia-Pacific Economic Cooperation. Mr. Sternberg has also served or serves on the boards of several public or private companies and charitable organizations. Mr. Sternberg is currently a director of CIT Group Inc. and a director of Northeastern University.

Seymour Sternberg, 1992年3月被任命为快捷药方董事。1997年4月被任命为纽约人寿首席执行官兼董事会主席,直到2008年6月从首席执行官职位上退下。他一直担任纽约人寿董事会非执行主席,直到2009年5月才退休。他被前总统克林顿任命为亚太经济合作组织工商咨询理事会三大代表之一。他曾经担任并一直担任多个上市公司、私人公司和慈善组织董事。现任西北大学和CIT有限集团董事。

Nicholas J. LaHowchic
Nicholas J. LaHowchic, 2001年7月被任命为快捷药方董事。现任Diannic有限责任公司(一家管理咨询公司)总裁兼首席执行官,2007年才退下。先前,曾与1997年10月起担任有限物流服务公司总裁兼首席执行官,从2004年4月到2007年2月担任有限品牌责任有限公司(一个服装零售公司,LLS公司的前身)执行副总裁。LLS专为零售商(包括有限品牌公司)提供供应链、合规和采购服务。曾任推进汽车零部件有限公司董事。
Nicholas J. LaHowchic,was elected a director of Express Scripts in July 2001. Mr. LaHowchic is currently President and Chief Executive Officer of Diannic, LLC, a management consulting firm, and has served in this capacity since 2007. Previously, he served as President and Chief Executive Officer of Limited Logistics Services, Inc. or “LLS,” from October 1997 and as Executive Vice President for Limited Brands, Inc., a retail apparel company and the parent of LLS, from April 2004 until his retirement in February 2007. LLS provides supply chain, compliance and procurement services to retailers including Limited Brands, Inc. Mr. LaHowchic previously served as a director of Advance Auto Parts, Inc.
Nicholas J. LaHowchic,was elected a director of Express Scripts in July 2001. Mr. LaHowchic is currently President and Chief Executive Officer of Diannic, LLC, a management consulting firm, and has served in this capacity since 2007. Previously, he served as President and Chief Executive Officer of Limited Logistics Services, Inc. or “LLS,” from October 1997 and as Executive Vice President for Limited Brands, Inc., a retail apparel company and the parent of LLS, from April 2004 until his retirement in February 2007. LLS provides supply chain, compliance and procurement services to retailers including Limited Brands, Inc. Mr. LaHowchic previously served as a director of Advance Auto Parts, Inc.

Nicholas J. LaHowchic, 2001年7月被任命为快捷药方董事。现任Diannic有限责任公司(一家管理咨询公司)总裁兼首席执行官,2007年才退下。先前,曾与1997年10月起担任有限物流服务公司总裁兼首席执行官,从2004年4月到2007年2月担任有限品牌责任有限公司(一个服装零售公司,LLS公司的前身)执行副总裁。LLS专为零售商(包括有限品牌公司)提供供应链、合规和采购服务。曾任推进汽车零部件有限公司董事。

Maura C. Breen
暂无中文简介
Maura C. Breen, was elected a director of Express Scripts in July 2004. Ms. Breen served as Senior Vice President and General Manager for the New York Region for Verizon Communications, Inc. or “Verizon,” a provider of communications services, from March 2006 until her retirement in September 2008. Previously, Ms. Breen was Senior Vice President/Support Services, Network Services Group for Verizon, from December 2003 through March 2006. Ms. Breen also served as Senior Vice President & Chief Marketing Officer, Retail Market Groups for Verizon from July 2001 through December 2003. Ms. Breen also serves as Chair of the Crohn’s & Colitis Foundation of America.
Maura C. Breen, was elected a director of Express Scripts in July 2004. Ms. Breen served as Senior Vice President and General Manager for the New York Region for Verizon Communications, Inc. or “Verizon,” a provider of communications services, from March 2006 until her retirement in September 2008. Previously, Ms. Breen was Senior Vice President/Support Services, Network Services Group for Verizon, from December 2003 through March 2006. Ms. Breen also served as Senior Vice President & Chief Marketing Officer, Retail Market Groups for Verizon from July 2001 through December 2003. Ms. Breen also serves as Chair of the Crohn’s & Colitis Foundation of America.

暂无中文简介
William L. Roper
William L. Roper, MD, MPH,2012年4月被正式任命为美国快捷药方公司董事。2007年12月至2012年4月Medco交易完成期间,他曾担任Medco Health Solutions, Inc.董事。2004年起担任北卡罗莱纳大学(UNC)教堂山分校医学院院长和医学事务校长和北卡罗来纳大学卫生保健系统CEO。他还担任了UNC医学院儿科和社会医学教授,以及UNC公共卫生学院卫生政策和行政管理教授。在1997年加入UNC之前,他曾于1993-1997年担任Prudential Health Care高就副总裁和其他职位。1990-1993年他还担任疾病控制和预防中心董事,1989年和1990年担任高级白宫幕僚,1986-1989年担任SMS管理者。2001年起担任DaVita HealthCare Partners Inc.董事。他是国家质量论坛(一家私人非营利公共福利公司,它的建立是为了促进卫生保健质量衡量和报告的标准化)董事会成员及前任董事会主席。
William L. Roper has been one of our directors since May 2001. Dr. Roper has been chief executive officer of the University of North Carolina "UNC" Health Care System, dean of the UNC School of Medicine and vice chancellor for medical affairs of UNC since March 2004. Dr. Roper also continues to serve as a professor of health policy and administration in the UNC School of Public Health and a professor of pediatrics and of social medicine in the UNC School of Medicine. From 1997 until March 2004 he was dean of the UNC School of Public Health. Before joining UNC in 1997 Dr. Roper served as senior vice president of Prudential Health Care. He also served as director of the Centers for Disease Control and Prevention from 1990 to 1993 on the senior White House staff in 1989 and 1990 and as the administrator of Centers for Medicare & Medicaid Services from 1986 to 1989. Dr. Roper was a member of and is the immediate past chairman of the board of the National Quality Forum, a non-profit organization that aims to improve the quality of healthcare. From December 2007 to November 2011 Dr. Roper served on the board of Medco Health Solutions, Inc., a pharmacy benefits management company, and since November 2011 has served on the board of its successor company, Express Scripts Holding Company.
William L. Roper has been one of our directors since May 2001. Dr. Roper has been chief executive officer of the University of North Carolina "UNC" Health Care System, dean of the UNC School of Medicine and vice chancellor for medical affairs of UNC since March 2004. Dr. Roper also continues to serve as a professor of health policy and administration in the UNC School of Public Health and a professor of pediatrics and of social medicine in the UNC School of Medicine. From 1997 until March 2004 he was dean of the UNC School of Public Health. Before joining UNC in 1997 Dr. Roper served as senior vice president of Prudential Health Care. He also served as director of the Centers for Disease Control and Prevention from 1990 to 1993 on the senior White House staff in 1989 and 1990 and as the administrator of Centers for Medicare & Medicaid Services from 1986 to 1989. Dr. Roper was a member of and is the immediate past chairman of the board of the National Quality Forum, a non-profit organization that aims to improve the quality of healthcare. From December 2007 to November 2011 Dr. Roper served on the board of Medco Health Solutions, Inc., a pharmacy benefits management company, and since November 2011 has served on the board of its successor company, Express Scripts Holding Company.

William L. Roper, MD, MPH,2012年4月被正式任命为美国快捷药方公司董事。2007年12月至2012年4月Medco交易完成期间,他曾担任Medco Health Solutions, Inc.董事。2004年起担任北卡罗莱纳大学(UNC)教堂山分校医学院院长和医学事务校长和北卡罗来纳大学卫生保健系统CEO。他还担任了UNC医学院儿科和社会医学教授,以及UNC公共卫生学院卫生政策和行政管理教授。在1997年加入UNC之前,他曾于1993-1997年担任Prudential Health Care高就副总裁和其他职位。1990-1993年他还担任疾病控制和预防中心董事,1989年和1990年担任高级白宫幕僚,1986-1989年担任SMS管理者。2001年起担任DaVita HealthCare Partners Inc.董事。他是国家质量论坛(一家私人非营利公共福利公司,它的建立是为了促进卫生保健质量衡量和报告的标准化)董事会成员及前任董事会主席。

Roderick A. Palmore
Roderick A. Palmore,加入通用磨坊公司,负责全球制造商的食品产品和营销,并在2008年2月担任为执行副总裁,总法律顾问,首席合规与风险管理主任和秘书。从1996年开始直到2008年,他为Sara Lee公司担任领导角色负责各种法律工作。他最终成为执行副总裁,总法律顾问兼秘书。在1996年之前,他曾在美国司法部的部门工作和私人执业。
Roderick A. Palmore is Senior Counsel at Dentons where he advises public and private corporations and their leadership suites on risk management and governance issues across practices and industry sectors. Mr. Palmore retired from his position as executive vice president, general counsel and chief compliance and risk management officer of General Mills, Inc. in February 2015 and has served on the Board of CBOE Holdings since our initial public offering in 2010 and of CBOE since 2000. Prior to joining General Mills in February 2008 he served as executive vice president and general counsel of Sara Lee Corporation. Before joining Sara Lee, Mr. Palmore served in the U.S. Attorney's Office in Chicago and in private practice. Mr. Palmore is currently a member of the boards of directors of The Goodyear Tire & Rubber Company and Express Scripts Holding Company and has previously served as a member of the boards of directors of Nuveen Investments, Inc. and the United Way of Metropolitan Chicago. Mr. Palmore holds a B.A. degree in Economics from Yale University and a J.D. degree from the University of Chicago Law School.
Roderick A. Palmore is Senior Counsel at Dentons where he advises public and private corporations and their leadership suites on risk management and governance issues across practices and industry sectors. Mr. Palmore retired from his position as executive vice president, general counsel and chief compliance and risk management officer of General Mills, Inc. in February 2015 and has served on the Board of CBOE Holdings since our initial public offering in 2010 and of CBOE since 2000. Prior to joining General Mills in February 2008 he served as executive vice president and general counsel of Sara Lee Corporation. Before joining Sara Lee, Mr. Palmore served in the U.S. Attorney's Office in Chicago and in private practice. Mr. Palmore is currently a member of the boards of directors of The Goodyear Tire & Rubber Company and Express Scripts Holding Company and has previously served as a member of the boards of directors of Nuveen Investments, Inc. and the United Way of Metropolitan Chicago. Mr. Palmore holds a B.A. degree in Economics from Yale University and a J.D. degree from the University of Chicago Law School.

Roderick A. Palmore,加入通用磨坊公司,负责全球制造商的食品产品和营销,并在2008年2月担任为执行副总裁,总法律顾问,首席合规与风险管理主任和秘书。从1996年开始直到2008年,他为Sara Lee公司担任领导角色负责各种法律工作。他最终成为执行副总裁,总法律顾问兼秘书。在1996年之前,他曾在美国司法部的部门工作和私人执业。

Elder Granger
暂无中文简介
Elder Granger was elected to our Board of Directors in November 2014. Dr. Granger is a U.S. Army Major General retired and the President and Chief Executive Officer of The 5Ps LLC. Dr. Granger previously served as an advisor to DLH on its strategic advisory board from October 2011 until his election to the Board. Dr. Granger served in the U.S. Army for over 35 years and was the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. from 2005 to 2009. In this role he served as the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DoD health plan, policy and performance. He oversaw the acquisition, operation and integration of DoD’s managed care program within the Military Health System. Prior to joining TRICARE Management Activity, Dr. Granger led the largest U.S. and multi-national battlefield health system in our recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. Presently, Dr. Granger is the President and CEO of The 5Ps, LLC, a healthcare, education, and leadership consultancy he founded following his retirement from the U.S. Army. Dr. Granger received a B.S. Degree from Arkansas State University and earned his medical degree from University of Arkansas School of Medicine. Upon graduation from the University of Arkansas School of Medicine, he was awarded the Henry Kaiser Medical Fellowship for Medical Excellence and Leadership. Dr. Granger is board certified by the American College of Physician Executives, American Board of Medical Quality, American Board of Internal Medicine, Medical Oncology, Hematology, and holds numerous medical certifications. As a National Association of Corporate Director, Fellow, Dr. Granger currently serves on the board of directors of Express Scripts Holding Co. (member - Compliance Committee) and is also a current and former advisor or member of the board of directors of additional privately-held companies.
Elder Granger was elected to our Board of Directors in November 2014. Dr. Granger is a U.S. Army Major General retired and the President and Chief Executive Officer of The 5Ps LLC. Dr. Granger previously served as an advisor to DLH on its strategic advisory board from October 2011 until his election to the Board. Dr. Granger served in the U.S. Army for over 35 years and was the Deputy Director and Program Executive Officer of the TRICARE Management Activity, Office of the Assistant Secretary of Defense (Health Affairs) in Washington, D.C. from 2005 to 2009. In this role he served as the principal advisor to the Assistant Secretary of Defense (Health Affairs) on DoD health plan, policy and performance. He oversaw the acquisition, operation and integration of DoD’s managed care program within the Military Health System. Prior to joining TRICARE Management Activity, Dr. Granger led the largest U.S. and multi-national battlefield health system in our recent history while serving as Commander, Task Force 44th Medical Command and Command Surgeon for the Multinational Corps Iraq. Presently, Dr. Granger is the President and CEO of The 5Ps, LLC, a healthcare, education, and leadership consultancy he founded following his retirement from the U.S. Army. Dr. Granger received a B.S. Degree from Arkansas State University and earned his medical degree from University of Arkansas School of Medicine. Upon graduation from the University of Arkansas School of Medicine, he was awarded the Henry Kaiser Medical Fellowship for Medical Excellence and Leadership. Dr. Granger is board certified by the American College of Physician Executives, American Board of Medical Quality, American Board of Internal Medicine, Medical Oncology, Hematology, and holds numerous medical certifications. As a National Association of Corporate Director, Fellow, Dr. Granger currently serves on the board of directors of Express Scripts Holding Co. (member - Compliance Committee) and is also a current and former advisor or member of the board of directors of additional privately-held companies.

暂无中文简介

高管简历

中文 |  英文 |  中英对照
Timothy Wentworth
Timothy Wentworth , 2014年2月被任命为公司总裁。从2012年4月到2014年2月,担任销售与客户管理部门高级副总裁。2012年4月快捷药方公司与美可保健公司合并,他于此时加入快捷药方公司。在美可保健公司,他从2008年10月到2012年4月担任全国重要客户集团总裁;2006年3月到2008年10月担任美可保健的附属子公司Accredo健康集团首席执行光;2003年8月到2006年3月担任全国客户集团总裁。
Timothy Wentworth assumed the role of Chief Executive Officer on May 4 2016 and has served as President of the Company since February 2014. Mr. Wentworth was elected a director of the Company in June 2015. From April 2012 to February 2014 he served as Senior Vice President and President, Sales and Account Management. Mr. Wentworth joined Express Scripts when the Company merged with Medco in April 2012. At Medco, he served as Group President, National and Key Accounts from October 2008 to April 2012 as Chief Executive Officer of Medco’s Accredo Health Group subsidiary from March 2006 to October 2008 and as Group President - National Accounts from August 2003 to March 2006.
Timothy Wentworth assumed the role of Chief Executive Officer on May 4 2016 and has served as President of the Company since February 2014. Mr. Wentworth was elected a director of the Company in June 2015. From April 2012 to February 2014 he served as Senior Vice President and President, Sales and Account Management. Mr. Wentworth joined Express Scripts when the Company merged with Medco in April 2012. At Medco, he served as Group President, National and Key Accounts from October 2008 to April 2012 as Chief Executive Officer of Medco’s Accredo Health Group subsidiary from March 2006 to October 2008 and as Group President - National Accounts from August 2003 to March 2006.

Timothy Wentworth , 2014年2月被任命为公司总裁。从2012年4月到2014年2月,担任销售与客户管理部门高级副总裁。2012年4月快捷药方公司与美可保健公司合并,他于此时加入快捷药方公司。在美可保健公司,他从2008年10月到2012年4月担任全国重要客户集团总裁;2006年3月到2008年10月担任美可保健的附属子公司Accredo健康集团首席执行光;2003年8月到2006年3月担任全国客户集团总裁。

Sara Wade
Sara Wade, 2010年被任命为高级副总裁兼首席人力资源官。在此之前,她曾于2009年6月到2010年12月担任公司薪酬与福利部门副总裁。之前她曾任职于可口可乐公司,2008年4月至2009年6月担任薪酬与福利部门公司副总裁;2007年11月到2008年4月担任爱国者煤炭公司人力转高级副总裁。
Sara Wadewas named Senior Vice President and Chief Human Resources Officer in December 2010 and previously served as Vice President, Compensation and Benefits from June 2009 to December 2010. Prior to joining Express Scripts, she served at Coca Cola Enterprises as Corporate Vice President, Compensation and Benefits from April 2008 to June 2009 and at Patriot Coal Corporation as Senior Vice President, Human Resources from November 2007 to April 2008.
Sara Wadewas named Senior Vice President and Chief Human Resources Officer in December 2010 and previously served as Vice President, Compensation and Benefits from June 2009 to December 2010. Prior to joining Express Scripts, she served at Coca Cola Enterprises as Corporate Vice President, Compensation and Benefits from April 2008 to June 2009 and at Patriot Coal Corporation as Senior Vice President, Human Resources from November 2007 to April 2008.

Sara Wade, 2010年被任命为高级副总裁兼首席人力资源官。在此之前,她曾于2009年6月到2010年12月担任公司薪酬与福利部门副总裁。之前她曾任职于可口可乐公司,2008年4月至2009年6月担任薪酬与福利部门公司副总裁;2007年11月到2008年4月担任爱国者煤炭公司人力转高级副总裁。

Christine Houston
Christine Houston, 2014年2月被任命为运营部高级副总裁。从2012年2月到2014年2月,担任制药和零售部门高级副总裁;2009年1月到2012年2月担任运营部副总裁和总经理的职位。1997年加入公司,并在信息科技和运营部门担任多个领导职位。
Christine Houston was named Executive Vice President and Chief Operations Officer in December 2016 and previously served as Senior Vice President, Operations from February 2014 to December 2016. From February 2012 to February 2014 she served as Senior Vice President, Pharma and Retail Relations and from January 2009 to February 2012 she served as Vice President/General Manager, Operations. Ms. Houston joined Express Scripts in September 1997 and has served in various leadership positions in Information Technology and Operations.
Christine Houston was named Executive Vice President and Chief Operations Officer in December 2016 and previously served as Senior Vice President, Operations from February 2014 to December 2016. From February 2012 to February 2014 she served as Senior Vice President, Pharma and Retail Relations and from January 2009 to February 2012 she served as Vice President/General Manager, Operations. Ms. Houston joined Express Scripts in September 1997 and has served in various leadership positions in Information Technology and Operations.

Christine Houston, 2014年2月被任命为运营部高级副总裁。从2012年2月到2014年2月,担任制药和零售部门高级副总裁;2009年1月到2012年2月担任运营部副总裁和总经理的职位。1997年加入公司,并在信息科技和运营部门担任多个领导职位。

Eric Slusser
Eric Slusser,他于2015年9月被任命为公司的执行副总裁兼首席财务官。加入Express Scripts公司之前,他曾担任Gentiva Health Services公司的执行副总裁、首席财务官兼财务主管(从2010年5月到2015年2月),以及高级财务副总裁(从2009年10月到2010年5月)。他此前也曾担任Centene Corporation的多种高级职务,包括执行副总裁,负责国际发展(从2009年5月到2009年10月)、执行副总裁兼首席财务官(从2007年7月到2009年5月)、财务主管(从2008年2月到2009年7月)。加入Centene Corporation之前,他曾担任Cardinal Health公司的财务执行副总裁、首席会计官和总会计师(2006年至2007年)。
Eric Slusser was named Executive Vice President and Chief Financial Officer of the Company in September 2015. Prior to joining Express Scripts, Mr. Slusser served as Executive Vice President, Chief Financial Officer and Treasurer of Gentiva Health Services, Inc., a provider of home healthcare services, from May 2010 to February 2015 and as Senior Vice President, Finance from October 2009 to May 2010. Mr. Slusser also previously served in various senior roles at Centene Corporation, including Executive Vice President, International Development from May 2009 to October 2009 Executive Vice President and Chief Financial Officer from July 2007 to May 2009 and Treasurer from February 2008 to July 2009. Prior to joining Centene Corporation, Mr. Slusser served as Executive Vice President, Finance, Chief Accounting Officer and Controller of Cardinal Health, Inc. from 2006 to 2007.
Eric Slusser was named Executive Vice President and Chief Financial Officer of the Company in September 2015. Prior to joining Express Scripts, Mr. Slusser served as Executive Vice President, Chief Financial Officer and Treasurer of Gentiva Health Services, Inc., a provider of home healthcare services, from May 2010 to February 2015 and as Senior Vice President, Finance from October 2009 to May 2010. Mr. Slusser also previously served in various senior roles at Centene Corporation, including Executive Vice President, International Development from May 2009 to October 2009 Executive Vice President and Chief Financial Officer from July 2007 to May 2009 and Treasurer from February 2008 to July 2009. Prior to joining Centene Corporation, Mr. Slusser served as Executive Vice President, Finance, Chief Accounting Officer and Controller of Cardinal Health, Inc. from 2006 to 2007.

Eric Slusser,他于2015年9月被任命为公司的执行副总裁兼首席财务官。加入Express Scripts公司之前,他曾担任Gentiva Health Services公司的执行副总裁、首席财务官兼财务主管(从2010年5月到2015年2月),以及高级财务副总裁(从2009年10月到2010年5月)。他此前也曾担任Centene Corporation的多种高级职务,包括执行副总裁,负责国际发展(从2009年5月到2009年10月)、执行副总裁兼首席财务官(从2007年7月到2009年5月)、财务主管(从2008年2月到2009年7月)。加入Centene Corporation之前,他曾担任Cardinal Health公司的财务执行副总裁、首席会计官和总会计师(2006年至2007年)。

Phyllis Anderson
Phyllis Anderson,她于2013年12月被任命为公司的首席营销官,也曾担任高级副总裁(2015年10月以来)。加入Express Scripts公司之前,她曾担任Humana Insurance Company的营销副总裁(2005年3月至2013年10月)。她也曾担任Bank of America的副总裁,负责战略计划—消费者房地产,以及Duke Energy Corporation的市场品牌和战略董事。
Phyllis Anderson was named the Company’s Chief Marketing Officer in December 2013 and has also served as a Senior Vice President since October 2015. Prior to joining Express Scripts, Ms. Anderson served as Vice President, Marketing at Humana Insurance Company from March 2005 to October 2013. Ms. Anderson also served as Vice President, Strategic Initiatives - Consumer Real Estate at Bank of America and Director, Market Brand and Strategy at Duke Energy Corporation.
Phyllis Anderson was named the Company’s Chief Marketing Officer in December 2013 and has also served as a Senior Vice President since October 2015. Prior to joining Express Scripts, Ms. Anderson served as Vice President, Marketing at Humana Insurance Company from March 2005 to October 2013. Ms. Anderson also served as Vice President, Strategic Initiatives - Consumer Real Estate at Bank of America and Director, Market Brand and Strategy at Duke Energy Corporation.

Phyllis Anderson,她于2013年12月被任命为公司的首席营销官,也曾担任高级副总裁(2015年10月以来)。加入Express Scripts公司之前,她曾担任Humana Insurance Company的营销副总裁(2005年3月至2013年10月)。她也曾担任Bank of America的副总裁,负责战略计划—消费者房地产,以及Duke Energy Corporation的市场品牌和战略董事。

Martin Akins
Martin Akins,他于2013年10月被任命为高级副总裁兼法律总顾问,也曾于担任公司的公司秘书(2013年5月以来)。他也曾担任副总裁兼副法律总顾问(从2010年2月到2015年10月),以及副总裁兼副法律总顾问(从2008年12月到2010年2月)。他于2001年2月加入公司,担任助理总法律顾问。加入Express Scripts公司之前,他曾担任Polsinelli PC的股东。
Martin Akins was named Senior Vice President and General Counsel in October 2015 and has served as Corporate Secretary since May 2013. Mr. Akins also served as Vice President and Deputy General Counsel from February 2010 to October 2015 and as Vice President and Associate General Counsel from December 2008 to February 2010. Mr. Akins joined the Company in February 2001 as Associate General Counsel. Prior to joining Express Scripts, Mr. Akins was a Shareholder at Polsinelli PC.
Martin Akins was named Senior Vice President and General Counsel in October 2015 and has served as Corporate Secretary since May 2013. Mr. Akins also served as Vice President and Deputy General Counsel from February 2010 to October 2015 and as Vice President and Associate General Counsel from December 2008 to February 2010. Mr. Akins joined the Company in February 2001 as Associate General Counsel. Prior to joining Express Scripts, Mr. Akins was a Shareholder at Polsinelli PC.

Martin Akins,他于2013年10月被任命为高级副总裁兼法律总顾问,也曾于担任公司的公司秘书(2013年5月以来)。他也曾担任副总裁兼副法律总顾问(从2010年2月到2015年10月),以及副总裁兼副法律总顾问(从2008年12月到2010年2月)。他于2001年2月加入公司,担任助理总法律顾问。加入Express Scripts公司之前,他曾担任Polsinelli PC的股东。

Steven Miller
Steven Miller, 2007年10月被任命为高级副总裁兼首席医务官。2005年4月加入快捷药方担任产品研发副总裁。
Steven Miller was named Senior Vice President and Chief Medical Officer in October 2007. Dr. Miller joined Express Scripts in April 2005 as Vice President, Research and Product.
Steven Miller was named Senior Vice President and Chief Medical Officer in October 2007. Dr. Miller joined Express Scripts in April 2005 as Vice President, Research and Product.

Steven Miller, 2007年10月被任命为高级副总裁兼首席医务官。2005年4月加入快捷药方担任产品研发副总裁。

Everett Neville
Everett Neville,他于2015年3月被任命为高级副总裁,负责供应链。从2009年3月到2015年3月,他担任副总裁,负责制药公司战略和承包。他一直任职公司16年以上。加入Express Scripts公司之前,他曾担任多种临床职务,包括医院和护理管理,作为福利顾问、药剂师和药房董事。
Everett Neville was named Senior Vice President, Supply Chain in March 2015 and assumed the role of Senior Vice President, Supply Chain & Specialty in November 2016. From March 2009 to March 2015 he served as Vice President, Pharma Strategy and Contracting. Mr. Neville has been with the Company for over 17 years. Prior to joining Express Scripts, Mr.Neville served in multiple clinical settings, including hospital and managed care, as a benefit consultant, pharmacist and pharmacy director.
Everett Neville was named Senior Vice President, Supply Chain in March 2015 and assumed the role of Senior Vice President, Supply Chain & Specialty in November 2016. From March 2009 to March 2015 he served as Vice President, Pharma Strategy and Contracting. Mr. Neville has been with the Company for over 17 years. Prior to joining Express Scripts, Mr.Neville served in multiple clinical settings, including hospital and managed care, as a benefit consultant, pharmacist and pharmacy director.

Everett Neville,他于2015年3月被任命为高级副总裁,负责供应链。从2009年3月到2015年3月,他担任副总裁,负责制药公司战略和承包。他一直任职公司16年以上。加入Express Scripts公司之前,他曾担任多种临床职务,包括医院和护理管理,作为福利顾问、药剂师和药房董事。

David Queller
David Queller,2014年7月以来,他曾担任我们的高级销售副总裁、会计经理。加入Express Scripts公司之前,他曾担任Aetna公司的多种高级领导职务,包括高级副总裁,负责国民核算(2013年1月至2014年6月)、多个国家地区的总裁(从2005年5月到2013年1月)。他于2000年10月加入Aetna公司。
David Queller was named Senior Vice President, Sales and Account Management in July 2014. Prior to joining Express Scripts, he served in a number of senior leadership positions at Aetna, Inc., a healthcare benefits company, including Senior Vice President, National Accounts from January 2013 to June 2014 and President of various national regions from May 2005 to January 2013. Mr. Queller joined Aetna Inc. in October 2000.
David Queller was named Senior Vice President, Sales and Account Management in July 2014. Prior to joining Express Scripts, he served in a number of senior leadership positions at Aetna, Inc., a healthcare benefits company, including Senior Vice President, National Accounts from January 2013 to June 2014 and President of various national regions from May 2005 to January 2013. Mr. Queller joined Aetna Inc. in October 2000.

David Queller,2014年7月以来,他曾担任我们的高级销售副总裁、会计经理。加入Express Scripts公司之前,他曾担任Aetna公司的多种高级领导职务,包括高级副总裁,负责国民核算(2013年1月至2014年6月)、多个国家地区的总裁(从2005年5月到2013年1月)。他于2000年10月加入Aetna公司。

Neal Sample
Neal Sample,2014年9月以来成为Enterprise Growth总裁。之前,2012年4月以来,他一直是Enterprise Growth 执行副总裁,首席信息官和首席营销技术专家。Sample先生从eBay加入American Express,2011年5月到2012年4月,在eBay担任 X.commerce,eBay的开放开发和商务平台首席技术官。之前,2010年9月到2011年5月,他是eBay的架构和平台产品副总裁。之前,2008年到2010年,他是雅虎副总裁。
Neal Sample was named Senior Vice President and Chief Information Officer of the Company in February 2016. Prior to joining Express Scripts, Dr. Sample served as President, Enterprise Growth at American Express, a global services, payments and travel company, from August 2014 to February 2016 as Chief Information Officer, Enterprise Growth at American Express from April 2012 to August 2014 as Chief Technology Officer, Commerce from May 2011 to April 2012 and as Vice President, Architecture, Technology Product Management at eBay from September 2010 to May 2011. He also served in various roles of increasing responsibility at Yahoo! from 2004 to 2010.
Neal Sample was named Senior Vice President and Chief Information Officer of the Company in February 2016. Prior to joining Express Scripts, Dr. Sample served as President, Enterprise Growth at American Express, a global services, payments and travel company, from August 2014 to February 2016 as Chief Information Officer, Enterprise Growth at American Express from April 2012 to August 2014 as Chief Technology Officer, Commerce from May 2011 to April 2012 and as Vice President, Architecture, Technology Product Management at eBay from September 2010 to May 2011. He also served in various roles of increasing responsibility at Yahoo! from 2004 to 2010.

Neal Sample,2014年9月以来成为Enterprise Growth总裁。之前,2012年4月以来,他一直是Enterprise Growth 执行副总裁,首席信息官和首席营销技术专家。Sample先生从eBay加入American Express,2011年5月到2012年4月,在eBay担任 X.commerce,eBay的开放开发和商务平台首席技术官。之前,2010年9月到2011年5月,他是eBay的架构和平台产品副总裁。之前,2008年到2010年,他是雅虎副总裁。

Christopher McGinnis
Christopher McGinnis,他于2015年9月被任命为副总裁、首席会计官和总会计师。此前,他曾担任财务和投资者关系副总裁(从2014年8月到2015年8月)、法律和业务开发的副总裁(从2012年4月到2014年7月)、助理总法律顾问(从2010年4月到2012年4月)。2008年3月加入Express Scripts公司之前,他曾担任American Water Works Company的多种法律和商业开发职务。
Christopher McGinnis was named Vice President, Chief Accounting Officer, and Controller in September 2015. Previously, Mr. McGinnis served as Vice President, Finance and Investor Relations from August 2014 to August 2015 as Vice President, Legal and Business Development from April 2012 to July 2014 and as Assistant General Counsel from April 2010 to April 2012. Prior to joining Express Scripts in March 2008 Mr. McGinnis held various accounting, finance, legal and business development roles.
Christopher McGinnis was named Vice President, Chief Accounting Officer, and Controller in September 2015. Previously, Mr. McGinnis served as Vice President, Finance and Investor Relations from August 2014 to August 2015 as Vice President, Legal and Business Development from April 2012 to July 2014 and as Assistant General Counsel from April 2010 to April 2012. Prior to joining Express Scripts in March 2008 Mr. McGinnis held various accounting, finance, legal and business development roles.

Christopher McGinnis,他于2015年9月被任命为副总裁、首席会计官和总会计师。此前,他曾担任财务和投资者关系副总裁(从2014年8月到2015年8月)、法律和业务开发的副总裁(从2012年4月到2014年7月)、助理总法律顾问(从2010年4月到2012年4月)。2008年3月加入Express Scripts公司之前,他曾担任American Water Works Company的多种法律和商业开发职务。

Glen Stettin
Glen Stettin.Dr., 2012年4月被任命为临床研究和新解决办法部门高级副总裁。2010年12月到2012年4月在美可保健公司担任高级副总裁兼首席医务官,并在2003年7月成为高级副总裁。2010年4月美可保健公司和快捷药方合并,他加入快捷药方公司。自1995年加入美可保健之后,在多个职能领域担任领导职位,包括产品、科技、临床和运营。
Glen Stettin was named Chief Innovation Officer in October 2015 and has also served as Senior Vice President, Clinical Research and New Solutions since April 2012. Dr. Stettin joined Express Scripts when the Company merged with Medco in April 2012 where he previously served as Chief Medical Officer from December 2010 to April 2012 and as Senior Vice President from July 2003 to April 2012. After joining Medco in 1995 Dr. Stettin held a number of leadership positions in several functional areas, including product, technology, clinical and operations.
Glen Stettin was named Chief Innovation Officer in October 2015 and has also served as Senior Vice President, Clinical Research and New Solutions since April 2012. Dr. Stettin joined Express Scripts when the Company merged with Medco in April 2012 where he previously served as Chief Medical Officer from December 2010 to April 2012 and as Senior Vice President from July 2003 to April 2012. After joining Medco in 1995 Dr. Stettin held a number of leadership positions in several functional areas, including product, technology, clinical and operations.

Glen Stettin.Dr., 2012年4月被任命为临床研究和新解决办法部门高级副总裁。2010年12月到2012年4月在美可保健公司担任高级副总裁兼首席医务官,并在2003年7月成为高级副总裁。2010年4月美可保健公司和快捷药方合并,他加入快捷药方公司。自1995年加入美可保健之后,在多个职能领域担任领导职位,包括产品、科技、临床和运营。